ClariTrial | Search Clinical Trials

Explore/Prostate Cancer

Status

Phase

8,419 results for “Prostate Cancer”

Page 1 of 562

Terminated

Results posted

HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer

Phase 2Prostate Cancer

68-Ga RM2.68-Ga PSMA11PET/MRI

Andrei Iagaru4 participants1 site · United StatesCompletes Nov 2022

Compare CT.gov Full analysis →

Completed

White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer After Local Therapy

Phase 1Prostate Cancer

white button mushroom extractflow cytometryimmunologic technique+3 more

City of Hope Medical Center36 participants2 sites · United StatesCompletes Jun 2021

Compare CT.gov Full analysis →

Recruiting

Four-Timepoint Multi-tracer PET Imaging to Characterize Metastatic prOstate Cancer Heterogeneity

N/AmCRPC (Metastatic Castration-resistant Prostate Cancer)

PET Tracer

Frederic Pouliot45 participants1 site · CanadaCompletes Dec 2029

Compare CT.gov Full analysis →

Recruiting

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Phase 1Advanced Solid TumorUnresectable Solid TumorMetastatic Solid Tumor

CLSP-1025

Clasp Therapeutics, Inc.90 participants21 sites · United StatesCompletes Dec 2027

Compare CT.gov Full analysis →

Not Yet Recruiting

Addition of a Focal Boost in External Beam Radiotherapy for Locally Advanced Prostate Cancer by Online Adaptive MR-guided Radiotherapy

Phase 2Prostate CancerProstate Neoplasm

Ultrahypofractionated MR-guided radiotherapy boost

Radboud University Medical Center95 participants2 sites · NetherlandsCompletes Jul 2024

Compare CT.gov Full analysis →

Active

PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer

N/AProstate CancerAdvanced Renal Cell CarcinomaAdvanced Urothelial Carcinoma

Systemic therapyStrataNGS

University of California, San Francisco156 participants1 site · United StatesCompletes Mar 2027

Compare CT.gov Full analysis →

Recruiting

Dose Escalation For INtraprostatic LEsions

Phase 2Prostatic Neoplasms

Prostate SBRT with Focal BoostTriptorelin Injection

Ottawa Hospital Research Institute54 participants1 site · CanadaCompletes Jun 2027

Compare CT.gov Full analysis →

Completed

Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy

N/AMetastatic Prostate Cancer

HYPNO VR® device

Saint-Gregoire Private Hospital Center53 participants6 sites · France, PortugalCompletes Dec 2025

Compare CT.gov Full analysis →

Withdrawn

Insulin Resistance and Androgen Deprivation Therapy

Phase 2Prostate CancerInsulin Resistance

Pioglitazone 30 mgplacebo tablet

St. Louis University01 site · United StatesCompletes Jan 2023

Compare CT.gov Full analysis →

Terminated

Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer

Phase 1Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer

abiraterone acetatedietary interventiondietary intervention+3 more

OHSU Knight Cancer Institute3 participants1 site · United StatesCompletes Jun 2014

Compare CT.gov Full analysis →

Completed

Pillars4Life Trial

N/ABreast CancerLung CancerEsophageal Cancer

Pillars4Life

Duke University284 participants1 site · United StatesCompletes Oct 2016

Compare CT.gov Full analysis →

Completed

68Ga-PSMA PET in Diagnosing Metastasis in Patients With Ovarian Cancer

N/AOvarian Carcinoma

Gallium Ga 68-labeled PSMA-11Magnetic Resonance Imaging (MRI)Positron Emission Tomography (PET)

University of California, San Francisco7 participants1 site · United StatesCompletes Jun 2022

Compare CT.gov Full analysis →

Completed

Gallium-68 Citrate PET Used in Prostate Cancer

Early Phase 1Prostatic Neoplasms

Gallium-68 citratePositron Emission Tomography (PET)

Rahul Aggarwal39 participants1 site · United StatesCompletes Jun 2023

Compare CT.gov Full analysis →

Completed

International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer

Phase 2Prostate Cancer

OzarelixGoserelin

Spectrum Pharmaceuticals, Inc203 participants3 sites · United StatesCompletes Sep 2014

Compare CT.gov Full analysis →

UNKNOWN

Local Ablative Radiotherapy for OLIgoprogressive Castration Resistant Prostate Cancer

N/AOligometastatic DiseaseProstatic Cancer, Castration-Resistant

local ablative radiotherapy

Technische Universität Dresden66 participants1 site · GermanyCompletes Feb 2024

Compare CT.gov Full analysis →

1–15 of 8,419

Explore/Prostate Cancer

Status

Phase

8,419 results for “Prostate Cancer”

Page 1 of 562

Terminated

Results posted

HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer

Phase 2Prostate Cancer

68-Ga RM2.68-Ga PSMA11PET/MRI

Andrei Iagaru4 participants1 site · United StatesCompletes Nov 2022

Compare CT.gov Full analysis →

Completed

White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer After Local Therapy

Phase 1Prostate Cancer

white button mushroom extractflow cytometryimmunologic technique+3 more

City of Hope Medical Center36 participants2 sites · United StatesCompletes Jun 2021

Compare CT.gov Full analysis →

Recruiting

Four-Timepoint Multi-tracer PET Imaging to Characterize Metastatic prOstate Cancer Heterogeneity

N/AmCRPC (Metastatic Castration-resistant Prostate Cancer)

PET Tracer

Frederic Pouliot45 participants1 site · CanadaCompletes Dec 2029

Compare CT.gov Full analysis →

Recruiting

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Phase 1Advanced Solid TumorUnresectable Solid TumorMetastatic Solid Tumor

CLSP-1025

Clasp Therapeutics, Inc.90 participants21 sites · United StatesCompletes Dec 2027

Compare CT.gov Full analysis →

Not Yet Recruiting

Addition of a Focal Boost in External Beam Radiotherapy for Locally Advanced Prostate Cancer by Online Adaptive MR-guided Radiotherapy

Phase 2Prostate CancerProstate Neoplasm

Ultrahypofractionated MR-guided radiotherapy boost

Radboud University Medical Center95 participants2 sites · NetherlandsCompletes Jul 2024

Compare CT.gov Full analysis →

Active

PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer

N/AProstate CancerAdvanced Renal Cell CarcinomaAdvanced Urothelial Carcinoma

Systemic therapyStrataNGS

University of California, San Francisco156 participants1 site · United StatesCompletes Mar 2027

Compare CT.gov Full analysis →

Recruiting

Dose Escalation For INtraprostatic LEsions

Phase 2Prostatic Neoplasms

Prostate SBRT with Focal BoostTriptorelin Injection

Ottawa Hospital Research Institute54 participants1 site · CanadaCompletes Jun 2027

Compare CT.gov Full analysis →

Completed

Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy

N/AMetastatic Prostate Cancer

HYPNO VR® device

Saint-Gregoire Private Hospital Center53 participants6 sites · France, PortugalCompletes Dec 2025

Compare CT.gov Full analysis →

Withdrawn

Insulin Resistance and Androgen Deprivation Therapy

Phase 2Prostate CancerInsulin Resistance

Pioglitazone 30 mgplacebo tablet

St. Louis University01 site · United StatesCompletes Jan 2023

Compare CT.gov Full analysis →

Terminated

Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer

Phase 1Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer

abiraterone acetatedietary interventiondietary intervention+3 more

OHSU Knight Cancer Institute3 participants1 site · United StatesCompletes Jun 2014

Compare CT.gov Full analysis →

Completed

Pillars4Life Trial

N/ABreast CancerLung CancerEsophageal Cancer

Pillars4Life

Duke University284 participants1 site · United StatesCompletes Oct 2016

Compare CT.gov Full analysis →

Completed

68Ga-PSMA PET in Diagnosing Metastasis in Patients With Ovarian Cancer

N/AOvarian Carcinoma

Gallium Ga 68-labeled PSMA-11Magnetic Resonance Imaging (MRI)Positron Emission Tomography (PET)

University of California, San Francisco7 participants1 site · United StatesCompletes Jun 2022

Compare CT.gov Full analysis →

Completed

Gallium-68 Citrate PET Used in Prostate Cancer

Early Phase 1Prostatic Neoplasms

Gallium-68 citratePositron Emission Tomography (PET)

Rahul Aggarwal39 participants1 site · United StatesCompletes Jun 2023

Compare CT.gov Full analysis →

Completed

International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer

Phase 2Prostate Cancer

OzarelixGoserelin

Spectrum Pharmaceuticals, Inc203 participants3 sites · United StatesCompletes Sep 2014

Compare CT.gov Full analysis →

UNKNOWN

Local Ablative Radiotherapy for OLIgoprogressive Castration Resistant Prostate Cancer

N/AOligometastatic DiseaseProstatic Cancer, Castration-Resistant

local ablative radiotherapy

Technische Universität Dresden66 participants1 site · GermanyCompletes Feb 2024

Compare CT.gov Full analysis →

1–15 of 8,419